RECRUITING

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.

Official Title

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness. A Randomized Controlled Trial.

Quick Facts

Study Start:2025-08-31
Study Completion:2027-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07053969

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Ability of subject to understand and the willingness to sign a written informed consent document.
  2. 2. Males and females; Age 18 to 89 years old
  3. 3. Require second stage implant uncovering
  4. 4. In either the maxillary or mandibular arch
  5. 5. Has consistent transportation for all clinical and study visits
  1. 1. Pregnancy, or those planning to become pregnant
  2. 2. Allergy or any medical issue using EMD
  3. 3. Non-English speaking
  4. 4. Patients on anticoagulants
  5. 5. Patients who object to the use of animal products

Contacts and Locations

Study Contact

Angela Palaiologou-Gallis, DDS
CONTACT
210-450-3715
PalaiologouA@uthscsa.edu

Principal Investigator

Angela Palaiologou-Gallis, DDS
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at San Antonio

Study Locations (Sites)

University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

  • Angela Palaiologou-Gallis, DDS, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center at San Antonio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-31
Study Completion Date2027-09

Study Record Updates

Study Start Date2025-08-31
Study Completion Date2027-09

Terms related to this study

Keywords Provided by Researchers

  • Enamel Matrix Derivatives
  • EMD
  • Keratinized mucosa width
  • Mucosal thickness

Additional Relevant MeSH Terms

  • Dental Implantation
  • Missing Teeth
  • Periodontitis, Adult
  • Mucositis